Leishmaniasis.
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy / Q000503:physiopathology* / Q000635:transmission; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy / Q000503:physiopathology / Q000635:transmission; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000503:physiopathology / Q000635:transmission
D000981:Antiprotozoal Agents